P1073 Real-World Effectiveness, Symptomatic Improvement, and Safety of Upadacitinib in Patients With Moderate-to-Severe Ulcerative Colitis: Interim Findings From the PROFUNDUS Study

R Panaccione, M Fumery, D Bettenworth, S Danese, P Morisset, M Mallick, S Chen, J Kim, S Suravaram, G Parkes

Open source

DOI
10.1093/ecco-jcc/jjaf231.1254
Published
2026-02-18
Container
Not recorded
Publisher
Oxford University Press
Open access
yes

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjaf231.1254,
  title = {P1073 Real-World Effectiveness, Symptomatic Improvement, and Safety of Upadacitinib in Patients With Moderate-to-Severe Ulcerative Colitis: Interim Findings From the PROFUNDUS Study},
  author = {R Panaccione and M Fumery and D Bettenworth and S Danese and P Morisset and M Mallick and S Chen and J Kim and S Suravaram and G Parkes},
  year = {2026},
  doi = {10.1093/ecco-jcc/jjaf231.1254},
  url = {https://doi.org/10.1093/ecco-jcc/jjaf231.1254}
}

RIS

TY  - JOUR
TI  - P1073 Real-World Effectiveness, Symptomatic Improvement, and Safety of Upadacitinib in Patients With Moderate-to-Severe Ulcerative Colitis: Interim Findings From the PROFUNDUS Study
AU  - R Panaccione
AU  - M Fumery
AU  - D Bettenworth
AU  - S Danese
AU  - P Morisset
AU  - M Mallick
AU  - S Chen
AU  - J Kim
AU  - S Suravaram
AU  - G Parkes
PY  - 2026
DO  - 10.1093/ecco-jcc/jjaf231.1254
UR  - https://doi.org/10.1093/ecco-jcc/jjaf231.1254
ER  - 

APA

Panaccione, R., Fumery, M., Bettenworth, D., Danese, S., Morisset, P., Mallick, M., Chen, S., Kim, J., Suravaram, S., & Parkes, G. (2026). P1073 Real-World Effectiveness, Symptomatic Improvement, and Safety of Upadacitinib in Patients With Moderate-to-Severe Ulcerative Colitis: Interim Findings From the PROFUNDUS Study. https://doi.org/10.1093/ecco-jcc/jjaf231.1254

Source records